Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

KORU Medical Systems, Inc. - Common Stock (NQ:KRMD)

3.480 +0.020 (+0.58%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about KORU Medical Systems, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
Breaking The Hospital Chain: Analyst On How KORU's Self-Administered Therapies Promise 20% CAGR Through 2026
B. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 7, 2023
 
Via Benzinga
Earnings Preview For KORU Medical Systems
 
Via Benzinga
Repro-Med Systems's Return On Capital Employed Overview
 
Via Benzinga
A Preview Of Repro-Med Systems's Earnings
 
Via Benzinga
Repro-Med Systems Earnings Perspective: Return On Capital Employed
 
Via Benzinga
KORU Medical Systems: Q2 Earnings Insights
KORU Medical Systems (NASDAQ:KRMD) reported its Q2 earnings results on Wednesday, August 3, 2022 at 04:00 PM. Here's what investors need to know about the announcement. 
Via Benzinga
KORU Medical Systems, Inc. Announces 2023 Second Quarter Financial Results and Updates Full Year 2023 Outlook
From KORU Medical Systems, Inc.
Via Business Wire
KORU Medical Systems to Participate in the Genuity 43rd Annual Growth Conference
From KORU Medical Systems
Via Business Wire
KORU Medical Systems, Inc. Announces Preliminary Second Quarter 2023 Revenues and Provides Business, Outlook and Executive Updates
From KORU Medical Systems, Inc.
Via Business Wire
KORU Medical Systems to Report Second Quarter Financial Results on August 9, 2023
From KORU Medical Systems
Via Business Wire
KORU Medical Systems Announces Novel Therapies Collaboration for Late-Stage Endocrinological Biologic
From KORU Medical Systems, Inc.
Via Business Wire
KORU Medical Systems, Inc. Announces 510(K) Submission for Freedom60® Infusion System With Hizentra® 50 Ml Prefilled Syringes
From KORU Medical Systems, Inc.
Via Business Wire
KORU Medical Systems, Inc. Names Andrew LaFrence as Chief Financial Officer
From KORU Medical Systems, Inc.
Via Business Wire
KORU Medical Systems, Inc. Announces 2023 First Quarter Financial Results
From KORU Medical Systems, Inc.
Via Business Wire
KORU Medical Systems to Report First Quarter Financial Results on May 4, 2023
From KORU Medical Systems
Via Business Wire
KORU Medical Systems Announces 2022 Q4 and Full Year Financial Results, Accelerating to 19% Revenue Growth in 2022
From KORU Medical Systems, Inc.
Via Business Wire
KORU Medical Systems to Report Fourth Quarter and Full Year 2022 Financial Results on March 8, 2023
From KORU Medical Systems
Via Business Wire
Earnings Scheduled For March 8, 2023
Companies Reporting Before The Bell • Daktronics (NASDAQ:DAKT) is expected to report quarterly earnings at $0.00 per share on revenue of $164.68 million. 
Via Benzinga
KORU Medical Systems Announces Subcutaneous Immunoglobulin Prefilled Syringe Development Agreement
From KORU Medical Systems, Inc.
Via Business Wire
KORU Medical Systems to Participate in the Piper Sandler 34th Annual Healthcare Conference
From KORU Medical Systems
Via Business Wire
KORU Medical Systems to Participate in Upcoming Investor Conferences
From KORU Medical Systems
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For November 10, 2022
Upgrades 
Via Benzinga
KORU Medical Systems Announces 2022 Third Quarter Financial Results
From KORU Medical Systems, Inc.
Via Business Wire
KORU Medical Systems Announces Novel Therapy Collaboration for Three Indications with Kira Pharmaceuticals
From KORU Medical Systems, Inc.
Via Business Wire
KORU Medical Systems to Report Third Quarter 2022 Financial Results on November 9, 2022
From KORU Medical Systems
Via Business Wire
KORU Medical Systems to Participate in Upcoming Industry Conferences
From KORU Medical Systems, Inc.
Via Business Wire
KORU Medical Systems Appoints Brent Rutland as Vice President of Medical Affairs
From KORU Medical Systems, Inc.
Via Business Wire
KORU Medical Systems Joins Subcutaneous Drug Development & Delivery Consortium
From KORU Medical Systems, Inc.
Via Business Wire
KORU Medical Systems Announces 2022 Second Quarter Financial Results
From KORU Medical Systems, Inc.
Via Business Wire
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.